FR2081436A1 - - Google Patents
Info
- Publication number
- FR2081436A1 FR2081436A1 FR7101185A FR7101185A FR2081436A1 FR 2081436 A1 FR2081436 A1 FR 2081436A1 FR 7101185 A FR7101185 A FR 7101185A FR 7101185 A FR7101185 A FR 7101185A FR 2081436 A1 FR2081436 A1 FR 2081436A1
- Authority
- FR
- France
- Prior art keywords
- jan
- active ingredient
- drug
- enhanced
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/609—Amides, e.g. salicylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
Abstract
1302471 Medicines with enhanced absorption R P SCHERER CORP 13 Jan 1971 [15 Jan 1970 26 Aug 1970] 1754/71 Heading A5B Pharmaceutical compositions for oral administration having enhanced gastrointestinal adsorption comprise an active ingredient and, as carrier, from 10-95% by weight of a block copolymer of general formula: wherein b is an integer of at least 17 and a and c are non-zero integers, the groups (CH 2 -CH 2 -O) a and (CH 2 -CH 2 -O) c together accounting for from 5 to 80% of the total molecular weight. The active ingredient is preferably an antibiotic, e.g., tetracycline, chloramphenicol or grineofulvin, but may be another medicament which is a steroidal hexane, a corticosteroid synthetic estrogen, thiazide diuretic, carbamate or phenothiazine tranquilizer, antihypertensive, nitrate ester cardiac vasodilator, coumarin-derived anticoagulant, analgesic, barbiturate, sulpha drug, digitalis glycoside, sulphonyl urea hypoglycemic, urinary antiseptic, antitubercular drug or non-steroid anti-inflammatory agent.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US318870A | 1970-01-15 | 1970-01-15 | |
US6727670A | 1970-08-26 | 1970-08-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2081436A1 true FR2081436A1 (en) | 1971-12-03 |
FR2081436B1 FR2081436B1 (en) | 1974-08-30 |
Family
ID=26671450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7101185A Expired FR2081436B1 (en) | 1970-01-15 | 1971-01-14 |
Country Status (3)
Country | Link |
---|---|
CA (1) | CA959759A (en) |
FR (1) | FR2081436B1 (en) |
GB (1) | GB1302471A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7409832A (en) * | 1973-07-20 | 1975-01-22 | Scherer Ltd R P | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS. |
FR2287900A1 (en) * | 1974-10-16 | 1976-05-14 | Arnar Stone Lab | GELATIN ENCAPSULATED DIGOXIN SOLUTIONS AND THEIR PREPARATION |
FR2500302A1 (en) * | 1981-02-25 | 1982-08-27 | Negma Laboratoires | Indomethacin antiinflammatory compsn. with reduced gastric irritation - uses liquid, oil or paste excipients contg. lipid(s), opt. hydroxylated polyether oxide(s) |
WO1987007149A1 (en) * | 1986-05-27 | 1987-12-03 | Sandoz Ag | Pharmaceutical compositions |
WO1988006038A1 (en) * | 1987-02-20 | 1988-08-25 | Emory University | Antiinfective compounds and method of use |
EP0317780A1 (en) * | 1987-11-25 | 1989-05-31 | American Cyanamid Company | Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers |
US5674911A (en) * | 1987-02-20 | 1997-10-07 | Cytrx Corporation | Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use |
US5811088A (en) * | 1987-02-20 | 1998-09-22 | Emory University | Antiinfective compounds and methods of use |
US5990241A (en) * | 1991-03-19 | 1999-11-23 | Cytrx, Corporation | Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
US6933286B2 (en) | 1991-03-19 | 2005-08-23 | R. Martin Emanuele | Therapeutic delivery compositions and methods of use thereof |
US7202225B1 (en) | 1993-10-15 | 2007-04-10 | Emanuele R Martin | Therapeutic delivery compositions and methods of use thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2281697A (en) * | 1993-09-14 | 1995-03-15 | Euro Celtique Sa | Laxative compositions in capsules |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB983132A (en) * | 1962-04-06 | 1965-02-10 | American Cyanamid Co | Improvements in or relating to chewable hematinic tablets |
NL6611190A (en) * | 1965-08-09 | 1967-02-10 | ||
FR2035770A1 (en) * | 1969-03-14 | 1970-12-24 | Orsymonde | Antispasmodic quercetin comp having - long lasting activity |
-
1971
- 1971-01-11 CA CA102,419A patent/CA959759A/en not_active Expired
- 1971-01-13 GB GB175471A patent/GB1302471A/en not_active Expired
- 1971-01-14 FR FR7101185A patent/FR2081436B1/fr not_active Expired
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB983132A (en) * | 1962-04-06 | 1965-02-10 | American Cyanamid Co | Improvements in or relating to chewable hematinic tablets |
NL6611190A (en) * | 1965-08-09 | 1967-02-10 | ||
FR2035770A1 (en) * | 1969-03-14 | 1970-12-24 | Orsymonde | Antispasmodic quercetin comp having - long lasting activity |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2237619A1 (en) * | 1973-07-20 | 1975-02-14 | Scherer Ltd R P | |
NL7409832A (en) * | 1973-07-20 | 1975-01-22 | Scherer Ltd R P | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS. |
FR2287900A1 (en) * | 1974-10-16 | 1976-05-14 | Arnar Stone Lab | GELATIN ENCAPSULATED DIGOXIN SOLUTIONS AND THEIR PREPARATION |
FR2500302A1 (en) * | 1981-02-25 | 1982-08-27 | Negma Laboratoires | Indomethacin antiinflammatory compsn. with reduced gastric irritation - uses liquid, oil or paste excipients contg. lipid(s), opt. hydroxylated polyether oxide(s) |
WO1987007149A1 (en) * | 1986-05-27 | 1987-12-03 | Sandoz Ag | Pharmaceutical compositions |
FR2599254A1 (en) * | 1986-05-27 | 1987-12-04 | Sandoz Sa | PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDES ADAPTED TO GASTROINTESTINAL RESORPTION. |
BE1000722A4 (en) * | 1986-05-27 | 1989-03-21 | Sandoz Sa | PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDES ADAPTED TO GASTROINTESTINAL RESORPTION. |
US5811088A (en) * | 1987-02-20 | 1998-09-22 | Emory University | Antiinfective compounds and methods of use |
WO1988006038A1 (en) * | 1987-02-20 | 1988-08-25 | Emory University | Antiinfective compounds and method of use |
US5674911A (en) * | 1987-02-20 | 1997-10-07 | Cytrx Corporation | Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use |
EP0317780A1 (en) * | 1987-11-25 | 1989-05-31 | American Cyanamid Company | Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers |
US5990241A (en) * | 1991-03-19 | 1999-11-23 | Cytrx, Corporation | Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
US6359014B1 (en) | 1991-03-19 | 2002-03-19 | Cytrx Corporation | Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
US6747064B2 (en) | 1991-03-19 | 2004-06-08 | Cytrx Corporation | Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
US6933286B2 (en) | 1991-03-19 | 2005-08-23 | R. Martin Emanuele | Therapeutic delivery compositions and methods of use thereof |
US7202225B1 (en) | 1993-10-15 | 2007-04-10 | Emanuele R Martin | Therapeutic delivery compositions and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
FR2081436B1 (en) | 1974-08-30 |
GB1302471A (en) | 1973-01-10 |
CA959759A (en) | 1974-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2081436B1 (en) | ||
KR950007841A (en) | Sustained-release drug formulations containing tramadol salts | |
RU94046044A (en) | NEW 7β-SUBSTITUTED 4-AZA-5a-CHOLESTAN-ONES AS INHIBITORS OF 5a-REDUCTASE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF ITS PREPARING | |
CA2302568A1 (en) | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
ES461399A1 (en) | Epinine esters and pharmaceutical compositions thereof | |
IE43693L (en) | Androstane derivatives | |
ES465906A1 (en) | Prolonged-release pharmaceutical compositions for oral administration, their methods of making and use | |
ATE15048T1 (en) | 4''-EPI ERYTHROMYCIN A AND ITS DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS. | |
RU94046463A (en) | Antiandrogenic compound, drug precursor, pharmaceutical compositions, process for medical treatment or prevention of diseases | |
US3144387A (en) | Anti-inflammatory compositions | |
IE39443L (en) | Pharmaceutical compositions; 5-(substituted benzal)¹hydantoin derivatives | |
GB1488995A (en) | Compositions containing anti-androgenic compounds | |
GB1351437A (en) | N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity | |
US3920809A (en) | Dibenzo(b,d)pyranone dispersions | |
GB1511645A (en) | Sickle cell anaemia treatment | |
IE903914A1 (en) | Pyrimidine biosynthesis inhibitors useful as¹immunosuppressive agents | |
GB1326528A (en) | Method of contraception and compositions used therein | |
KR910006270A (en) | Pharmacologically active compound preparations and uses | |
GB1219700A (en) | Pharmaceutical compositions comprising lincomycin derivatives | |
US3316151A (en) | Methods and compositions for inducing tranquilizing, muscle relaxant and depressant activity | |
GB1352392A (en) | Phenylisopropylamine derivatives | |
IE45096L (en) | Thiadiazole derivatives | |
US3703580A (en) | Antibacterial medicinal compositions | |
GB1220793A (en) | Pharmaceutical compositions | |
GB1465771A (en) | Pharmaceutical composition and use thereofd |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |